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Abstract 
Background: This study aims to identify the major anti‑inflammatory components in the petroleum ether extract of 
Bupleurum malconense (Chaihu), by bioassay‑guided fractionation, and to investigate the anti‑inflammatory mecha‑
nisms of active components in lipopolysaccharide (LPS)‑stimulated murine macrophage RAW‑Blue cells.
Methods: A QUANTI‑Blue assay was used to guide fractionation of B. malconense root extract. The petroleum ether 
extract which exerted significant secreted embryonic alkaline phosphatase (SEAP) inhibition effect was purified by 
silica gel column chromatography and assisted with reverse phase HPLC. The major bioactive compound which sig‑
nificantly inhibited SEAP activity was obtained and its anti‑inflammatory effects in LPS‑induced RAW‑Blue cells were 
measured by the overproduction of NO (Griess method), gene expression of Il‑1β, Tnf‑α and iNos (real‑time PCR). In 
parallel, protein expressions of COX‑2, iNOS and IκB‑α were determined by western blot.
Results: In bioassay‑guided fractionation using LPS‑stimulated mouse macrophage RAW‑Blue cells, 
(+)‑3′‑angeloxyloxy‑4′‑keto‑3′,4′‑dihydroseselin (Pd‑Ib) was identified by MS and NMR spectral analyses. Pd‑Ib (5, 10, 
20 μg/mL) suppressed the gene expression of Il‑1β (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentra‑
tions), Tnf‑α (P = 0.006, P = 0.001, P < 0.0001 for three respective concentrations) and iNos (P = 0.009, P < 0.0001, 
P < 0.0001 for three respective concentrations) in LPS‑stimulated macrophages. The production of cyclooxygenase‑2 
(P = 0.019, P = 0.002, P < 0.0001), iNOS (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) and NO 
(P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) significantly decreased when macrophages 
were treated with Pd‑Ib (5, 10, 20 μg/mL) in the presence of LPS. Pd‑Ib (5, 10, 20 μg/mL) suppressed the nuclear acti‑
vation of NF‑κB while it up‑regulated the IκB‑α level (P = 0.028, P = 0.013, P = 0.005 for three respective concentra‑
tions) in LPS‑stimulated macrophages.
Conclusions: Pd‑Ib isolated from B. malconense suppressed LPS‑induced inflammatory responses in macrophages by 
inhibiting NF‑κB activity and reducing the expression of iNOS, COX‑2 as well as pro‑inflammatory cytokines.
© 2016 Mu et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Bupleurum is used for treatment of inflammation-related 
diseases, such as autoimmune diseases, inflamma-
tory bowel syndrome and cholecystitis [1–3]. Nearly 50 
Bupleurum species have been extensively studied for their 
phytochemical characteristics [4]. In general, the compo-
nents of Bupleurum include essential oil and saponins [5, 
6]. Saikosaponins are commonly recognized as the main 
components responsible for the anti-inflammatory activ-
ity of the Bupleurum species [7–9]. However, Bupleurum 
malconense, a species endemic to China, appears to lit-
tle be known its major bioactive components [10–12]. In 
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a preliminary study of our group, the anti-inflammatory 
effect of B. malconense was evaluated in dextran sulfate 
sodium (DSS)-induced colitis mouse model. The petro-
leum ether extract of B. malconense exerted strong ame-
liorative effect on colon shortening and loss of the body 
weight (Additional file  1). As saikosaponins are polar, 
we believed that some compounds less polar than sai-
kosaponins may be responsible for the anti-inflamma-
tory properties of the petroleum ether (PE) extract of B. 
malconense.
This study aims to identify the anti-inflammatory com-
ponents in the PE extract of B. malconense by QUANTI-
Blue bioassay-guided fractionation, and to investigate the 
anti-inflammatory actions of these active components in 
LPS-stimulated murine macrophage RAW-Blue cells.
Methods
Chemicals
Lipopolysaccharides (LPS, L3129), 3-[4, 5-dimethylth-
iazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT), 
dimethyl sulfoxide (DMSO), Griess reagent, and all 
chemicals used were of HPLC grade from Sigma Chemi-
cal Co. (St. Louis, MO, USA). Primers for inducible nitric 
oxide synthase gene (iNos), interleukin 1 beta gene (Il-1β) 
and tumor necrosis factor alpha gene (Tnf-α), beta-actin 
gene (β-Actin) (Table  1), Trizol reagent, SYBR Green, 
Dulbecco’s modified Eagle’s medium (DMEM), ECL 
reagent, fetal bovine serum (FBS), penicillin and strep-
tomycin were purchased from Life Technologies (Carls-
bad, CA, USA). BCA protein assay kit was purchased by 
Thermo Fisher Scientific (Waltham, MA, USA). Nuclear 
factor-kappa B (NF-κB), I-kappa B alpha (IκB-α), cycloox-
ygenase-2 (COX-2) and iNOS rabbit antibodies were 
purchased from Cell Signaling Technology (Beverly, MA, 
USA). β-actin mouse antibody, anti-rabbit IgG and anti-
mouse IgG were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA). QUANTI-Blue medium and 
Alexa Fluor568@ anti-rabbit IgG were purchased from 
InvivoGen (San Diego, CA, USA). Fractions were moni-
tored and combined by thin layer chromatography. Spots 
were made visible by heating silica gel plates that had 
been immersed in 5 % H2SO4 in ethanol (EtOH).
Plant material
The dried roots of B. malconense were collected from 
Sichuan Province, China. The plant material was identi-
fied and authenticated by Dr. Linfang Huang based on 
sequences of the plastid psbA-trnH intergenic region [13, 
14]. The sequences of plant material (ZSH1 and ZSH2) 
highly matched the sequence of B. malconense (GenBank 
accession: JN788921) (Additional file 2).
Extraction and isolation
Air-dried pieces of B. malconense root (500  g) were 
extracted three times by percolation in PE (1 L). The super-
natant, which was concentrated and collected, was the PE 
extract. The residue was extracted three times by reflux in 
80 % EtOH at 60 °C. The solution was concentrated to yield 
an 80 % EtOH. Then, the residue was further extracted by 
reflux in water (1 L) for three times to obtain the aqueous 
extract. Meanwhile, the 80 % EtOH extract was dissolved 
in 200 mL of water in a separatory funnel, and then parti-
tioned with ethyl acetate (EtOAc, 200 mL × 3). The upper 
and lower layers were collected to yield the EtOAc extract 
and EtOH extract, respectively. After freeze-drying (Lab-
conoco, Kansas, MO, USA), extracts were weighted, and 
the related percent composition was calculated, with the 
following results: PE extract (0.8 g, 0.2 %), EtOAc extract 
(4.7 g, 0.9 %), EtOH extract (25.3 g, 5.1 %), aqueous extract 
(24.2 g, 4.8 %). All extracts were stored at −20 °C.
The PE extract was subjected to silica gel column chro-
matography (300–400 mesh, Davisil, Germany) using PE/
EtOAc with increasing polarity as eluent. Pd-Ib, which 
was obtained from fraction 3 (Fr. 3) with 2.5 % EtOAc in 
PE, was further purified by reverse phase HPLC (Waters 
system including a 2545 binary gradient module, a 2489 
UV/Visible detector and a fraction collector III) on the 
semi-preparative column Preparative RP-C18 (Alltech 
Alltima-C18, 250  mm  ×  10  mm, 5  μm). The separation 
flow chart (together with bioassay) is shown in Fig. 1.
Anti‑inflammatory bioassay
RAW-Blue cells (5 ×  104/well) were cultured in 96-well 
plates for 24  h, and then treated with LPS (1  μg/mL) 
alone or together with test samples for 20  h. Secreted 
embryonic alkaline phosphatase (SEAP) activity in the 
medium was determined by QUANTI-Blue medium fol-
lowing the manufacturer’s instructions. Briefly, 100 μL of 
samples were added to 200 μL of QUANTI-Blue medium 
and incubated at 37  °C for 15–30 min. Absorbance was 
measured at 620 nm by a microplate reader (Benchmark 
plus Bio-Red, Hercules, CA, USA), and fold change in 
SEAP activity was calculated.
Table 1 Sequence of primers used in real-time PCR
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Cell culture
RAW-Blue cells were derived from RAW264.7 murine 
macrophages. RAW-Blue cells were cultured in plastic 
dishes containing DMEM supplemented with 100 U/mL 
penicillin, 100  μg/mL streptomycin and 10  % FBS in an 
incubator (5  % CO2) at 37  °C. Cells were sub-cultured 
every 3 days at a dilution of 1:6.
Cell viability assay
Cells (5 × 104/well) were cultured in 96-well plates for 
24  h, and then cultured with various concentrations 
of Pd-Ib (1.25, 2.5, 5, 10, 20, 40, 80, and 100  μg/mL) 
for 24  h. Then, 10  μL of 5  mg/mL MTT were added 
to each well, and the cells were cultured in the dark 
for 3 h. The medium was then discarded, and 100-μL 
portions of DMSO were added into each well. After 
15  min incubation, the optical density at 570  nm was 
measured by a microplate reader to determine the cell 
viability.
Western blot analysis
After RAW-Blue cells were treated with LPS (1 μg/mL) 
and various concentrations of Pd-Ib (5, 10, 20  μg/mL) 
for 24  h, total proteins were extracted by lysis buffer 
[150 mM NaCl, 1 mM EDTA, 1 % NP-40, 2 mM EGTA, 
50  mM Tris (pH 7.4)] with phosphatase and protease 
inhibitors (Roche, Mannheim, Germany). Cell extracts 
were centrifuged by centrifugation (5424R, Eppendorf, 
Hamburg, Germany) at 17,000×g for 15 min at 4 °C. The 
amount of total protein concentration was quantified 
by the BCA protein assay kit (Thermo Fisher Scientific, 
Waltham, MA, USA). Then, 10–25  μg proteins were 
loaded and separated on sodium dodecylsulphate-pol-
yacrylamide gel (10 % SDS-PAGE), which were further 
transferred onto polyvinylidene difluoride membranes. 
The membranes were incubated with various primary 
antibodies, namely, anti-COX-2, anti-iNOS, anti-IκB-α, 
and anti-β-actin (1:5000) in 5  % skim milk (wt/vol) in 
TBST overnight at 4  °C, after blocking with 5  % skim 
milk (wt/vol) in Tris-buffered saline-Tween [TBST; 
150  mM NaCl, 50  mM Tris, 0.05  % Tween-20 (pH 
7.4)] for 1 h. After washing with TBST for three times 
(10  min for each time), the membranes were blocked 
with secondary antibodies (1:2000) in 5  % skim milk 
(wt/vol) in TBST for 1 h, following with TBST washed 
(3 × 10 min). The amount of immunoreactive proteins 
was detected by enhanced chemiluminescence ECL 
reagent and X-ray film. The protein bands were quan-
tified using the ImageJ Software (version 4.1.7, NIH, 
Bethesda, MD, USA) by their relative intensity com-
pared with the control.
Immunofluorescence staining
RAW-Blue cells were cultured (2 × 105 cells/well) on glass 
coverslips and incubated for 24  h. Cells were pretreated 
with Pd-Ib (20 μg/mL) for 2 h and then with LPS (1 μg/mL) 
for 20  h. Subsequently, the coverslips were rinsed twice 
with phosphate buffer saline, and cells were fixed in 4  % 
paraformaldehyde in PBS at room temperature for 15 min. 
Cellular and nuclear membranes of the macrophages were 
permeabilized by treatment with 3 % Triton X-100 in PBS 
for 15  min. After being blocked with 3  % bovine serum 
albumin (BSA) in PBS for 1 h, the cells was incubated with 
primary antibodies in 3 % BSA/PBS (1:500 dilution) at 4 °C 
overnight. After washing with PBS, the cells were incubated 
with the Alexa Fluor568-conjugated secondary antibodies 
(1:500 dilution) in 3 % BSA/PBS at room temperature for 
1  h, and finally washed again three time with PBS. Then, 
counter-staining of nuclei was performed with 4′,6-diami-
dino-2-phenylindole (DAPI; 1:1000 dilution) in 3  % BSA/
Fig. 1 Flow chart of bioassay‑guided isolation of the anti‑inflam‑
matory compound of B. malconense. The effect of test samples on 
SEAP activity in LPS‑stimulated RAW‑Blue cells. *P < 0.05, **P < 0.01 
and ***P < 0.001 vs. LPS‑alone group. PE ext petroleum ether extract, 
EtOAc ethyl acetate extract, EtOH ethanol extract, H2O water extract, 
Fr fraction, con vehicle control group
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PBS for 10  min. The cells were washed three times with 
PBS, and then anti-fade mounting medium was added. 
Samples were observed under a fluorescence microscope 
(DMI3000B, Leisa Microsystems, Wetzlar, Germany).
Real‑time quantitative polymerase chain reaction (qPCR) 
analysis
2 × 106 cells/well RAW-Blue cells were seeded in 12-well 
plates. After 24 h, cells were pretreated with Pd-Ib at dif-
ferent concentrations (5–20  μg/mL) or untreated (con-
trol) for 2  h, following co-cultured with LPS (1  μg/mL) 
for 20  h. TRIzol reagent was used to extract the total 
RNA. Then, 2  μg of total RNA was reverse-transcribed 
to cDNA with RT master mix. Real-time qPCR was per-
formed with the SYBR Green kit in a ViiA7 real-time PCR 
instrument (Life Technologies, Waltham, Massachu-
setts, USA). The comparative cycle of threshold (ΔΔCT) 
method of relative quantification was used to analyze the 
target gene expression. The accuracy of the amplicon was 
verified using melting curve analysis. Primer sequences 
of Il-1β, Tnf-α, iNos and β-Actin for mRNA analysis are 
listed in Table 1.
Nitric oxide production determination
Nitric oxide (NO) production was indirectly assessed 
by measuring the nitrite levels in the cultured medium 
determined by a colorimetric method based on the Griess 
reagent and sodium nitrite as a standard substance. The 
cells were pretreated with various concentrations of 
Pd-Ib (5–20  μg/mL). Two hours later, cells were incu-
bated for another 20 h in the presence of LPS (1 μg/mL) 
at 37  °C. Then, 100 μL of each supernatant were mixed 
with an equal volume of Griess reagent. The samples 
were incubated at room temperature for 15  min. The 
optical densities were measured at 540  nm by a micro-
plate reader, and nitrite concentration was determined by 
a standard curve generated with known concentrations 
of sodium nitrite.
Statistical analysis
Experiments were performed at least three times as indi-
cated. Data were presented as mean  ±  SD from three 
independent experiments. Statistical differences among 
groups were evaluated by one-way analysis of variance 
(ANOVA) and Duncan’s multiple range test by IBM SPSS 
Statistics 20 for Windows (SPSS Inc., Chicago, IL, USA). 
P values <0.05 were considered statistically significant. 
The dose-dependence was visually determined.
Results and discussion
Bioassay‑guided isolation and structural identification
As shown in Fig.  1, upon LPS stimulation, The SEAP 
activity was significantly inhibited by the addition of 
the PE extract (50  μg/mL) (16.52–9.86  %, P  <  0.0001). 
Fig. 2 Effect of Pd‑Ib on the viability of LPS‑stimulated RAW‑Blue 
cells. Cells were cultured for 24 h in the presence of Pd‑Ib at the indi‑
cated concentrations (1.25–100 μg/mL). Cell viability was assessed by 
the MTT assay. Data were obtained from three independent experi‑
ments and presented as mean ± SD. con vehicle control group
Fig. 3 Effect of Pd‑Ib on inhibited the IκB‑α degradation in LPS‑stim‑
ulated RAW‑Blue cells. After macrophages were treated with 1 μg/
mL of LPS in absence or presence of various concentrations of Pd‑Ib 
(5, 10 and 20 μg/mL) for 20 h, the protein level of IκB‑α was deter‑
mined by western blotting, β‑actin was used as a loading control. a 
Representative image of western blotting. b The protein level of IκB‑α 
was calculated with ImageJ software. Data were derived from three 
independent experiments and presented as mean ± SD. # Compared 
with the control group. *P < 0.05 and **P < 0.01 vs. LPS‑alone group
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The PE extract was subjected to silica gel chromatog-
raphy using PE/EtOAc as an eluent and eight fractions 
were collected to further search for anti-inflammatory 
compounds. Because the SEAP activity was significantly 
inhibited by Fr. 3 (24.67–36.65  %, P  <  0.0001), further 
purification was carried out to isolate one pure com-
pound. This compound, which inhibited the SEAP 
activity (IC50 = 22.53 μg/mL) in the LPS-stimulated mac-
rophages in a dose-dependent manner, was determined 
to be Pd-Ib by HR-MS analysis (MicrOToF-Q Bruker 
mass spectrometer equipped with Acquity Waters ultra-
high performance liquid chromatography) and NMR 
spectra analysis (Bruker 400 Hz NMR spectrometer). The 
spectral data (Additional files 3 and 4) are identical to 
those reported [15–17]. To our knowledge, this is the first 
time that Pd-Ib has been found in B. malconense.
Pd-Ib yield: 2.38  mg of white powder (MeOH). 
HR-ESI+-MS: m/z 342.1183 [M+H]+ (calculated for 
C19H18O6, 342.1182). 1H-NMR (CDCl3, 400 MHz) δ: 6.35 
(1H, d, J = 9. 6 Hz, H-3), 7.63 (1H, d, J = 9.6 Hz, H-4), 
7.57 (1H, d, J  =  8.4  Hz, H-5), 6.90 (1H, d, J  =  8.8  Hz, 
H-6), 5.69 (1H, s, J = 4.8 Hz, H-3′), 1.62 (3H, s, 5′-CH3), 
1.45 (3H, s, 5′-CH3), 6.25 (1H, q, J = 7. 5 Hz, H-3″), 2.07 
(3H, d, J = 8.8 Hz, 4″-CH3), 2.00 (3H, s, 5″-CH3).
Cytotoxicity of Pd‑Ib in RAW‑Blue cells
The cytotoxic effect of Pd-Ib on RAW-Blue cells was 
tested with the MTT assay. As shown in Fig. 2, Pd-Ib did 
not exhibit cytotoxic effects at dosages ranging from 1.56 
to 20 μg/mL; however, the cell viability decreased when 
the macrophages were treated with Pd-Ib at doses of 40, 
80 or 100 μg/mL.
Fig. 4 Effect of Pd‑Ib on the nuclear translocation of NF‑κB. Macrophages were pre‑incubated with Pd‑Ib (20 μg/mL) for 2 h and then with or 
without 1 μg/mL of LPS for 20 h. And then Nuclei were stained with DAPI for immunofluorescence staining analysis. Data were derived from three 
independent experiments. Original magnification, ×40
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Pd‑Ib inhibited the nuclear translocation of NF‑κB 
and decreased degradation of IκB‑α in LPS‑stimulated 
RAW‑Blue cells
The SEAP activity in the supernatants of the LPS-stimu-
lated RAW-Blue cells reflects the activation of NF-κB [18]. 
NF-κB activation is involved in a number of cellular pro-
cesses, particularly inflammation. The inhibition of NF-κB 
activation was associated with the mitigation of colon 
inflammation responses and apoptosis of intestinal epithe-
lial cells in the DSS mouse model [19]. In our in vitro study, 
the immunofluorescence analysis showed that the nuclear 
translocation of NF-κB p65 subunit in the LPS-stimulated 
cells was remarkably up-regulated when comparing to that 
of the non-LPS-treated control, denoting the activation of 
NF-κB. When Pd-Ib (20 μg/mL) treatment was given, the 
translocation of NF-κB p65 was inhibited (Fig. 3).
In contrast, the expression of the inhibitory subunit 
of NF-κB, IκB-α was clearly depredated in macrophages 
upon LPS stimulation. From the western blotting images, 
we demonstrated that the loss of cytoplasmic IκB-α was 
inhibited by Pd-Ib (5, 10, 20  μg/mL) in a dose-depend-
ent manner when compared with the LPS-stimulated 
macrophages (P = 0.028, P = 0.013, P = 0.005 for three 
respective concentrations; Fig. 4).
Pd‑Ib suppressed the expression of iNOS and COX‑2 
in LPS‑stimulated RAW‑Blue cells
COX-2 and iNOS are known to mediate inflamma-
tory responses. High expression levels cause intestinal 
inflammation with motility dysfunction [20]. Pd-Ib (5, 10, 
20  μg/mL) strongly down-regulated iNOS (P  <  0.0001, 
P  <  0.0001, P  <  0.0001 for three respective concentra-
tions) and COX-2 (P = 0.019, P = 0.002, P < 0.0001 for 
three respective concentrations) protein levels in a dose-
dependent manner (Fig. 5a, b).
Furthermore, the effect of Pd-Ib on the mRNA expres-
sion of iNos was investigated in LPS-stimulated RAW-
Blue cells. As shown in Fig.  6a, Pd-Ib (5, 10, 20  μg/
mL) also markedly inhibited the mRNA level of iNos 
(P  <  0.0001, P  <  0.0001, P  <  0.0001 for three respective 
concentrations) in a dose-dependent manner. Pd-Ib plays 
a key role in the inhibition of iNOS protein and gene 
expression.
Pd‑Ib inhibited the mRNA expression of Tnf‑α and Il‑1β 
in LPS‑stimulated RAW‑Blue cells
High levels of pro-inflammatory cytokines are asso-
ciated with pain, lung inflammation and rheumatoid 
arthritis [21–23]. In this study, the mRNA expression 
of pro-inflammatory cytokines was examined by real-
time qPCR. As shown in Fig. 6b, c, Pd-Ib (5, 10, 20 μg/
mL) inhibited the mRNA expression of Tnf-α (P < 0.006, 
P < 0.001, P < 0.0001 for three respective concentrations) 
and Il-1β (P  <  0.001, P  <  0.0001, P  <  0.0001 for three 
respective concentrations) in a dose-dependent manner, 
while LPS stimulation of macrophages caused an increase 
in their expression.
Pd‑Ib inhibited NO production in LPS‑stimulated RAW‑Blue 
cells
Production of excessive amounts of NO leads to inflam-
matory responses or tissue injury [24]. As shown in 
Fig. 6d, LPS stimulation significantly increased NO pro-
duction compared with the control group, while treat-
ment with 5, 10 or 20 μg/mL Pd-Ib led to 17.64 ± 2.96, 
29.82 ± 1.34 and 55.45 ± 1.15 % (P < 0.0001, P < 0.0001, 
P < 0.0001 for three respective concentrations) inhibition 
of NO production, respectively.
Pd-Ib exerted anti-inflammatory effects through inhibi-
tion of SEAP activity in the QUANTI-Blue assay. SEAP 
is a reporter gene widely used to screen immune-phar-
macological activities upon the activation of NF-κB and 
activator protein 1 (AP-1) [25, 26]. When RAW-Blue 
Fig. 5 Inhibitory effect of Pd‑Ib on iNOS and COX‑2 expression in 
LPS‑stimulated RAW‑Blue cells. After macrophages were treated with 
1 μg/mL LPS in the absence or presence of various concentrations 
of Pd‑Ib (5, 10 and 20 μg/mL) for 20 h, the protein levels of iNOS 
and COX‑2 were determined by western blotting; β‑actin was used 
as a loading control. a Representative western blotting images. b 
The protein levels of iNOS and COX‑2 were calculated with ImageJ 
software. Data were derived from three independent experiments 
and presented as mean ± SD. #Compared with the control group. 
*P < 0.05, **P < 0.01 and ***P < 0.001 vs. LPS‑alone group
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cells are stimulated with LPS, IκB-α, which is the inhibi-
tory subunit of NF-κB, is rapidly phosphorylated. Sub-
sequently, NF-κB releases from the IκB-α subunit and 
translocates to the nucleus, where it increases the expres-
sion of the genes that encode many cytokines, enzymes 
and adhesion molecules [27]. Pd-Ib significantly inhibited 
the LPS-stimulated degradation of IκB-α and the nuclear 
translocation of NF-κB.
Increased expression of two key factors regulated by 
NF-κB, COX-2 and iNOS, is reflected in the increased 
amount of NO in the colon of patients with active ulcera-
tive colitis [28]. Pd-Ib significantly inhibited the protein 
expression of COX-2 and iNOS, resulting in a decrease 
in NO in activated macrophages. The results also suggest 
that Pd-Ib down-regulated the protein levels of iNOS by 
reducing its mRNA expression.
When the pro-inflammatory cytokines, includ-
ing TNF-α and IL-1β, are overproduced, often lead 
to inflammatory process [29]. Thus, inhibition of the 
release of pro-inflammatory cytokines may attenuate the 
inflammatory response [30]. Our qPCR results showed 
that Pd-Ib significantly down-regulated the mRNA 
expression of Tnf-α and Il-1β in a dose-dependent man-
ner. Our finding of Pd-Ib agreed to the previous studies 
[31–33] that many natural compounds inhibiting TNF-α 
activation suppress the nuclear expression of NF-κB.
Conclusion
Pd-Ib isolated from B. malconense suppressed LPS-
induced inflammatory responses in macrophages by 
inhibiting NF-κB activity and reducing the expression of 
iNOS, COX-2 as well as pro-inflammatory cytokines.
Fig. 6 Effect of pro‑inflammatory factors expression on nitric oxide production in LPS‑stimulated RAW‑Blue cells. After macrophages were treated 
with 1 μg/mL LPS in the absence or presence of various concentrations of Pd‑Ib (5, 10 and 20 μg/mL) for 20 h, the mRNA levels of iNos (a) Tnf‑α 
(b) and Il‑1β (c) were determined by real‑time PCR, and the production of NO (d) was determined by Griess reagent. Data were derived from three 
independent experiments and presented as mean ± SD. con vehicle control group. #Compared with the control group. *P < 0.05, **P < 0.01 and 
***P < 0.001 vs. LPS‑alone group
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